Showing 841-850 of 9077 results for "".
Word of Mouth Advertising Done Right
https://practicaldermatology.com/topics/practice-management/word-of-mouth-advertising-done-right/19064/Tracy Drumm, Vice President of IF Marketing shares insider tips for effective word of mouth advertising for the cosmetic or aesthetic practice.Psoriasis Q&A: Topical Treatments
https://practicaldermatology.com/topics/psoriasis/psoriasis-qa-topical-treatments/21376/Educating patients on the chronic nature of psoriasis is essential in boosting adherence and maximizing efficacy with topical agents.Management of the Periocular Area
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/management-of-the-periocular-area/19210/Richard Anderson, MD reviews his presentation on the proper approach to cosmetic management of the periocular area and mid-face at Vegas Cosmetic Surgery 2013. He discusses blepharoplasty, toxins, fillers, and more. VCS2013The Economical ADVANTAGE Diode Laser Treats Chest and Abs Hair In Under 5 Minutes
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-economical-advantage-diode-laser-treats-chest-and-abs-hair-in-under-5-minutes/19213/ADVANTAGE™ Diode Laser Hair Removal System, offers clinics an economical way to have speed and efficacy in a small footprint. The 10 x 30 mm handpiece delivers impressive speed for efficacious LHR as demonstrated by Dr. Melanie Palm. The male patient in this video has his unwanted chest and abs hairYour Website Architecture - Every Brick Counts, an Ekwa.com Educational Video
https://practicaldermatology.com/topics/practice-management/your-website-architecture-every-brick-counts/19340/An educational video explaining proper website architecture and menu placement for External uses. Visit Ekwa.com for more information.Dermwire TV: Ruxolitinib Cream 1.5% Effective for AD Improvement, Stapokibart Shows Promise
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-ruxolitinib-cream-15-effective-for-ad-improvement-stapokibart-shows-promise/49101/This episode highlights new research showing ruxolitinib cream 1.5% providing itch relief and broader atopic dermatitis (AD) improvement, as well as a post-hoc analysis finding safety and efficacy for stapokibart in elderly adults with AD; and Excellergy executives discuss how recent research validaDermwire TV: Topical Caffeine for Hair Growth, Tapinarof for Pediatric AD
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-topical-caffeine-for-hair-growth-tapinarof-for-pediatric-ad/48734/This episode highlights studies showing potential for topical caffeine in hair growth in patients with alopecia areata, as well as recent positive results for tapinarof cream 1% for children with AD. Also, Cutera CEO Taylor Harris talks with Practical Dermatology about the evolving needs of today’sDWTV Extra: Psoriasis Advocacy
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-psoriasis-advocacy/39890/International Federation of Psoriasis Associations (IFPA) executive director Frida Dunger discusses her organization's efforts to raise awareness, including a recent event involving the United Nations as well as World Psoriasis Day on October 29."Ask Me Anything" Mentorship Session With Dr. DiAnne Davis
https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-dianne-davis/39879/DiAnne Davis, MD, FAAD, discusses her career journey as a board-certified, fellowship trained cosmetic dermatologist with expertise in skin of color, laser and light-based procedures, neuromodulators, injectable fillers, platelet rich plasma (PRP), sclerotherapy, body contouring, acne scars, laser bSpecial Considerations for Biologic Therapies in Pediatric and Adult Patients with Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37173/Elizabeth Lippner, MD, MA, Attending Physician in the Division of Allergy and Immunology and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, lists some of the most important considerations when prescribing biologic therapies for atopic dermatitis patients of